28122499|t|Uridine stimulate laxative effect in the loperamide - induced constipation of SD rats through regulation of the mAChRs signaling pathway and mucin secretion
28122499|a|Uridine (Urd), which has been reported as a major component of RNA, plays an important role in various biological process including neuroprotection, biochemical modulation and glycolysis, although its role in constipation has yet to be established. Therefore, in this study, we investigated the laxative effects of Urd on chronic constipation. The constipation phenotypes and their related mechanisms were investigated in the transverse colons of SD rats with loperamide (Lop)- induced constipation after treatment with 100 mg/kg of Urd. The number, weight and water contents of stools were significantly higher in the Lop + Urd treated group than the Lop + Vehicle treated group, while food intake and water consumption of the same group were maintained at a constant level. The thickness of the mucosa layer, muscle and flat luminal surface, as well as the number of goblet cells, paneth cells and lipid droplets were enhanced in the Lop + Urd treated group. Furthermore, the expression of the muscarinic acetylcholine receptors M2 and M3 (mAChR M2 and M3) at the transcriptional and translational level was recovered in the Lop + Urd treated group, while some markers such as Gα and inositol triphosphate (IP3) in their downstream signaling pathway were completely recovered by Urd treatment. Moreover, the ability for mucin secretion and the expression of membrane water channel (aquaporine 8, AQP8) were increased significantly in the Lop + Urd treated group compared with Lop + Vehicle treated group. Finally, the activity of Urd was confirmed in primary smooth muscle of rat intestine cells (pRISMC) based on Gα expression and IP3 concentration. The results of the present study provide the first strong evidence that Urd can be considered an important candidate for improving chronic constipation induced by Lop treatment in animal models.
28122499	0	7	Uridine	T114,T121	C0041984
28122499	18	26	laxative	T121	C0282090
28122499	27	33	effect	T080	C1280500
28122499	41	51	loperamide	T109,T121	C0023992
28122499	54	61	induced	T169	C0205263
28122499	62	74	constipation	T184	C0009806
28122499	78	85	SD rats	T015	C2699239
28122499	94	104	regulation	T044	C1327386
28122499	112	118	mAChRs	T116,T192	C0034826
28122499	119	136	signaling pathway	T044	C0037080
28122499	141	146	mucin	T116,T123	C0026682
28122499	147	156	secretion	T038	C0036536
28122499	157	164	Uridine	T114,T121	C0041984
28122499	166	169	Urd	T114,T121	C0041984
28122499	187	195	reported	T058	C0700287
28122499	201	206	major	T080	C0205164
28122499	220	223	RNA	T114	C0035668
28122499	234	243	important	T080	C3898777
28122499	244	248	role	T077	C1705810
28122499	260	278	biological process	T038	C3714634
28122499	289	304	neuroprotection	T043	C0598958
28122499	306	328	biochemical modulation	UnknownType	C0678672
28122499	333	343	glycolysis	T044	C0017952
28122499	358	362	role	T077	C1705810
28122499	366	378	constipation	T184	C0009806
28122499	393	404	established	T080	C0443211
28122499	425	430	study	T062	C2603343
28122499	435	447	investigated	T169	C1292732
28122499	452	460	laxative	T121	C0282090
28122499	461	468	effects	T080	C1280500
28122499	472	475	Urd	T114,T121	C0041984
28122499	479	486	chronic	T079	C0205191
28122499	487	499	constipation	T184	C0009806
28122499	505	517	constipation	T184	C0009806
28122499	518	528	phenotypes	T032	C0031437
28122499	547	557	mechanisms	T169	C0441712
28122499	563	575	investigated	T169	C1292732
28122499	583	600	transverse colons	T023	C0227386
28122499	604	611	SD rats	T015	C2699239
28122499	617	627	loperamide	T109,T121	C0023992
28122499	629	632	Lop	T109,T121	C0023992
28122499	635	642	induced	T169	C0205263
28122499	643	655	constipation	T184	C0009806
28122499	662	671	treatment	T061	C0087111
28122499	690	693	Urd	T114,T121	C0041984
28122499	699	705	number	T081	C0237753
28122499	707	713	weight	T081	C0043100
28122499	718	723	water	T121,T197	C0043047
28122499	724	732	contents	T077	C0456205
28122499	736	742	stools	T031	C0015733
28122499	748	761	significantly	T078	C0750502
28122499	762	768	higher	T080	C0205250
28122499	776	779	Lop	T109,T121	C0023992
28122499	782	785	Urd	T114,T121	C0041984
28122499	786	793	treated	T033	C0332154
28122499	794	799	group	T078	C0441833
28122499	809	812	Lop	T109,T121	C0023992
28122499	815	822	Vehicle	T122	C0042444
28122499	823	830	treated	T033	C0332154
28122499	831	836	group	T078	C0441833
28122499	844	855	food intake	T040	C0013470
28122499	860	877	water consumption	T040	C0013123
28122499	890	895	group	T078	C0441833
28122499	917	925	constant	T080	C1948059
28122499	926	931	level	T080	C0441889
28122499	937	946	thickness	T080	C1280412
28122499	954	966	mucosa layer	T024	C0026724
28122499	968	974	muscle	T024	C0026845
28122499	979	999	flat luminal surface	T029	C1180160
28122499	1016	1022	number	T081	C0237753
28122499	1026	1038	goblet cells	T025	C0506994
28122499	1040	1052	paneth cells	T025	C0227276
28122499	1057	1071	lipid droplets	T026	C0230704
28122499	1077	1085	enhanced	T052	C2349975
28122499	1093	1096	Lop	T109,T121	C0023992
28122499	1099	1102	Urd	T114,T121	C0041984
28122499	1103	1110	treated	T033	C0332154
28122499	1111	1116	group	T078	C0441833
28122499	1135	1145	expression	T045	C1171362
28122499	1153	1190	muscarinic acetylcholine receptors M2	T116,T192	C0384752
28122499	1195	1197	M3	T116,T192	C0289799
28122499	1199	1207	mAChR M2	T116,T192	C0384752
28122499	1212	1214	M3	T116,T192	C0289799
28122499	1223	1238	transcriptional	T045	C1158770
28122499	1243	1256	translational	T045	C3537096
28122499	1257	1262	level	T080	C0441889
28122499	1267	1276	recovered	T080	C0521108
28122499	1284	1287	Lop	T109,T121	C0023992
28122499	1290	1293	Urd	T114,T121	C0041984
28122499	1294	1301	treated	T033	C0332154
28122499	1302	1307	group	T078	C0441833
28122499	1320	1327	markers	T201	C0005516
28122499	1336	1338	Gα	T116,T126	C0887847
28122499	1343	1364	inositol triphosphate	UnknownType	C0815032
28122499	1366	1369	IP3	UnknownType	C0815032
28122499	1380	1390	downstream	T082	C0522506
28122499	1391	1408	signaling pathway	T044	C0037080
28122499	1425	1434	recovered	T080	C0521108
28122499	1438	1441	Urd	T114,T121	C0041984
28122499	1442	1451	treatment	T061	C0087111
28122499	1479	1484	mucin	T116,T123	C0026682
28122499	1485	1494	secretion	T038	C0036536
28122499	1503	1513	expression	T045	C1171362
28122499	1517	1539	membrane water channel	T116,T123	C0599635
28122499	1541	1553	aquaporine 8	T116,T123	C1743716
28122499	1555	1559	AQP8	T116,T123	C1743716
28122499	1566	1575	increased	T081	C0205217
28122499	1576	1589	significantly	T078	C0750502
28122499	1597	1600	Lop	T109,T121	C0023992
28122499	1603	1606	Urd	T114,T121	C0041984
28122499	1607	1614	treated	T033	C0332154
28122499	1615	1620	group	T078	C0441833
28122499	1621	1629	compared	T052	C1707455
28122499	1635	1638	Lop	T109,T121	C0023992
28122499	1641	1648	Vehicle	T122	C0042444
28122499	1649	1656	treated	T033	C0332154
28122499	1657	1662	group	T078	C0441833
28122499	1677	1685	activity	T052	C0441655
28122499	1689	1692	Urd	T114,T121	C0041984
28122499	1710	1731	primary smooth muscle	T024	C1267092
28122499	1735	1738	rat	T015	C0086893
28122499	1739	1754	intestine cells	T025	C0814997
28122499	1756	1762	pRISMC	T025	C1135918
28122499	1773	1775	Gα	T116,T126	C0887847
28122499	1776	1786	expression	T045	C1171362
28122499	1791	1794	IP3	UnknownType	C0815032
28122499	1795	1808	concentration	T081	C1446561
28122499	1814	1821	results	T033	C0683954
28122499	1837	1842	study	T062	C2603343
28122499	1861	1867	strong	T080	C0442821
28122499	1868	1876	evidence	T078	C3887511
28122499	1882	1885	Urd	T114,T121	C0041984
28122499	1907	1916	important	T080	C3898777
28122499	1931	1940	improving	T080	C1272745
28122499	1941	1948	chronic	T079	C0205191
28122499	1949	1961	constipation	T184	C0009806
28122499	1962	1969	induced	T169	C0205263
28122499	1973	1976	Lop	T109,T121	C0023992
28122499	1977	1986	treatment	T061	C0087111
28122499	1990	2003	animal models	T008	C0599779